Glenview Capital Management, LLC Edwards Lifesciences Corp Transaction History

Glenview Capital Management, LLC

  • $5.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$67.19 - $87.44 $226,766 - $295,110
-3,375 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$57.54 - $76.95 $778,573 - $1.04 Million
-13,531 Reduced 80.04%
3,375 $233,000
Q1 2020

May 15, 2020
BUY
$52.41 - $81.0 $886,043 - $1.37 Million
16,906 New
16,906 $3.19 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email